FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: an Austrian observational Tri-Center comparative effectiveness analysis [Abstract]

Autor: Riedl, J., Posch, F., Horvath, L., Gantschnigg, A., Renneberg, F., Schwarzenbacher, E., Moik, F., Barth, D., Schaberl-Moser, R., Stotz, M., Pichler, Martin, Stöger, H., Greil, R., Djanani, A., Schlick, K., Gerger, A.
Jazyk: angličtina
Rok vydání: 2023
Databáze: OpenAIRE